These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7784974

  • 1. [The venous occlusion test in assessing the fibrinolytic activity of the vascular endothelium in lupus nephritis patients].
    Bobkova IN, Poliantseva LR, Tareeva IE, Andreenko GV, Podorol'skaia LV.
    Ter Arkh; 1995; 67(4):42-5. PubMed ID: 7784974
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Tissue-type plasminogen activator in patients with lupus nephritis].
    Poliantseva LG, Bobkova IN, Tareeva IE, Podorol'skaia LV, Andreenko GV.
    Ter Arkh; 1995; 67(5):17-9. PubMed ID: 7638768
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis].
    Smyr KV, Shcherbak AV, Kozlovskaia LV, Sokolova IA, Bobkova IN, Podorol'skaia LV.
    Ter Arkh; 2010; 82(1):47-51. PubMed ID: 20364701
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
    Stalder M, Hauert J, Bachmann F.
    Schweiz Med Wochenschr; 1983 Oct 08; 113(40):1462-4. PubMed ID: 6606226
    [Abstract] [Full Text] [Related]

  • 12. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF.
    J Lab Clin Med; 1993 Nov 08; 122(5):606-15. PubMed ID: 8228580
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of renal vascular lesions using circulating endothelial cells in patients with lupus nephritis.
    Yao G, Liu ZH, Zheng C, Zhang X, Chen H, Zeng C, Li LS.
    Rheumatology (Oxford); 2008 Apr 08; 47(4):432-6. PubMed ID: 18292121
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).
    Du XH, Glas-Greenwalt P, Kant KS, Allen CM, Hayes S, Pollak VE.
    Clin Nephrol; 1985 Oct 08; 24(4):186-91. PubMed ID: 3933871
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fibrinolytic activity in gastric venous blood. A comparison between normal and diseased stomachs.
    O'Brien TE, Hadley H, Irving MH.
    Gastroenterology; 1979 Mar 08; 76(3):509-14. PubMed ID: 155020
    [Abstract] [Full Text] [Related]

  • 19. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
    Kozlovskaia NL, Shilov EM, Meteleva NA, Varshavskiĭ VA, Miroshnichenko NG, Samokishina NA, Serova AG, Nesterova SG.
    Ter Arkh; 2006 Mar 08; 78(5):21-31. PubMed ID: 16889045
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.